Autolus Therapeutics plc AUTL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-22
Autolus Therapeutics plc institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,436,102 | $15.4M |
| RENAISSANCE TECHNOLOGIES LLC | 2,299,499 | $3.2M |
| CITADEL ADVISORS LLC | 585,804 | $808,410 |
| Point72 Asset Management, L.P. | 426,983 | $589,237 |
| MILLENNIUM MANAGEMENT LLC | 204,728 | $282,525 |
Source: SEC EDGAR filings · CIK 0001730463 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.